Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Journal of Clinical Lipidology

Volumn 9, Issue 4, 2015, Pages 576-582

  Sonmez, Alper ^a   Nikolic, Dragana ^b   Dogru, Teoman ^a   Ercin, Cemal Nuri ^a   Genc, Halil ^a   Cesur, Mustafa ^c   Tapan, Serkan ^a   Karslioʇlu, Yildirim ^a   Montalto, Giuseppe ^b   Banach, MacIej ^d   Toth, Peter P ^e,f,g   Bagci, Sait ^a   Rizzo, Manfredi ^b,h  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF PALERMO   (Italy)

^c GÜVEN HOSPITAL   (Turkey)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e CGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Euro Mediterranean Institute of Science and Technology   (Italy)

Author keywords

Lipids; Lipoproteins; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Simple steatosis

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 10; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN 4; HIGH DENSITY LIPOPROTEIN 5; HIGH DENSITY LIPOPROTEIN 6; HIGH DENSITY LIPOPROTEIN 7; HIGH DENSITY LIPOPROTEIN 8; HIGH DENSITY LIPOPROTEIN 9; INTERLEUKIN 6; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN 1; LOW DENSITY LIPOPROTEIN 2; LOW DENSITY LIPOPROTEIN 3; LOW DENSITY LIPOPROTEIN 4; LOW DENSITY LIPOPROTEIN 5; LOW DENSITY LIPOPROTEIN 6; LOW DENSITY LIPOPROTEIN 7; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER HISTOLOGY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; ATHEROSCLEROSIS; BLOOD; FATTY LIVER; FEMALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; ATHEROSCLEROSIS; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS;

EID: 84938204905     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.03.010     Document Type: Article

References (38)

1. N. Chalasani, Z. Younossi, J.E. Lavine, et al. American Gastroenterological A, American Association for the Study of Liver D, American College of G The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
2. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
3. C.D. Williams, J. Stengel, M.I. Asike, and et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
4. G. Bedogni, L. Miglioli, F. Masutti, and et al. Incidence and natural course of fatty liver in the general population: the Dionysos study Hepatology 46 2007 1387 1391
5. M. Rizzo, G. Montalto, and M. Vinciguerra Editorial: exploring lipid-related treatment options for the treatment of NASH Curr Vasc Pharmacol 12 2014 741 744
6. A. Torres do Rego, L. Perez de Isla, A. Saltijeral Cerezo, G. Vitale, A. Izarra, and L.A. Alvarez-Sala Walther Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease Eur J Intern Med 25 2014 438 443
7. G. Gianotti, A. Cenni, G. Bianchi, and et al. Pianoro Study G: diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? Arch Gerontol Geriatr 58 2014 188 195
8. D.M. Hurjui, O. Nita, L.I. Graur, and et al. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome Rev Med Chir Soc Med Nat Iasi 116 2012 692 699
9. G. Targher, L. Bertolini, S. Rodella, and et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men Obesity (Silver Spring) 16 2008 1394 1399
10. G. Musso, S. Bo, M. Cassader, F. De Michieli, and R. Gambino Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism Am J Clin Nutr 98 2013 895 906
11. L. Abenavoli, C. Luigiano, P.H. Guzzi, and et al. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease Panminerva Med 56 2014 189 193
12. V.W. Wong, A.Y. Hui, S.W. Tsang, and et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 4 2006 1154 1161
13. J.W. Haukeland, T.B. Dahl, A. Yndestad, and et al. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies Eur J Endocrinol 166 2012 503 510
14. T. Dogru, H. Genc, S. Tapan, and et al. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? Diabetes Res Clin Pract 96 2012 47 52
15. T. Dogru, H. Genc, S. Tapan, and et al. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease Clin Endocrinol (Oxf) 78 2013 712 717
16. M. Soresi, D. Noto, A.B. Cefalu, and et al. Metabolic Syndrome Study G: nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis Society Acta Diabetol 50 2013 241 249
17. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
18. F.G. Toledo, A.D. Sniderman, and D.E. Kelley Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes Diabetes Care 29 2006 1845 1850
19. M.S. Siddiqui, M. Fuchs, M. Idowu, and et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis associate with atherogenic lipoprotein profile Clin Gastroenterol Hepatol 13 2015 1000 1008.e3
20. S. Sookoian, T.F. Gianotti, M.S. Rosselli, A.L. Burgueno, G.O. Castano, and C.J. Pirola Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease Atherosclerosis 218 2011 378 385
21. H. Genc, T. Dogru, M. Kara, and et al. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease Ann Hepatol 12 2013 548 555
22. D.E. Kleiner, E.M. Brunt, M. Van Natta, and et al. Nonalcoholic steatohepatitis clinical research N: design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
23. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
24. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. E. Bonora, G. Targher, M. Alberiche, and et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 2000 57 63
26. N. Scichilone, M. Rizzo, A. Benfante, and et al. Serum low density lipoprotein subclasses in asthma Respir Med 107 2013 1866 1872
27. M. Rizzo, R.V. Giglio, D. Nikolic, and et al. Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study Angiology 65 2013 538 542
28. K. Berneis, M. Rizzo, H.K. Berthold, G.A. Spinas, W. Krone, and I. Gouni-Berthold Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial Eur Heart J 31 2010 1633 1639
29. D.P. Mikhailidis, M. Elisaf, M. Rizzo, and et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses Curr Vasc Pharmacol 9 2011 533 571
30. H.K. Berthold, M. Rizzo, N. Spenrath, G. Montalto, W. Krone, and I. Gouni-Berthold Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial PLoS One 9 2014 e91565
31. M. Rizzo, J. Otvos, D. Nikolic, G. Montalto, P.P. Toth, and M. Banach Subfractions and subpopulations of HDL: an update Curr Med Chem 21 2014 2881 2891
32. A.P. DeFilippis, M.J. Blaha, S.S. Martin, and et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis Atherosclerosis 227 2013 429 436
33. M.L. Phillips, S. Boase, S. Wahlroos, and et al. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery Diabetes Obes Metab 10 2008 661 667
34. M.S. Siddiqui, R.K. Sterling, V.A. Luketic, and et al. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis Gastroenterology 145 2013 1271 1279.e1-3
35. G. Targher Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease J Hepatol 45 2006 879 881 author reply 81-2
36. A. Wieckowska, B.G. Papouchado, Z. Li, R. Lopez, N.N. Zein, and A.E. Feldstein Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am J Gastroenterol 103 2008 1372 1379
37. C. Pagano, G. Soardo, W. Esposito, and et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease Eur J Endocrinol 152 2005 113 118
38. R. Rametta, M. Ruscica, P. Dongiovanni, and et al. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance Eur J Clin Invest 44 2014 627 633